{"id":71737,"date":"2026-04-15T14:01:42","date_gmt":"2026-04-15T08:31:42","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=71737"},"modified":"2026-04-15T14:01:44","modified_gmt":"2026-04-15T08:31:44","slug":"aurobindo-pharma-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/","title":{"rendered":"Aurobindo Pharma Share Price Target 2026: Analyst Forecast, Bull and Bear Case"},"content":{"rendered":"<p><strong>Aurobindo Pharma<\/strong> (NSE: AUROPHARMA) trades at Rs 1,150 as of April 2026 \u2014 against a 52-week high of Rs 1,600 and a 52-week low of Rs 1,050. The analyst consensus 12-month Aurobindo Pharma share price target is Rs 1,350\u20131,550, implying 17\u201335% upside. This article covers the key catalysts, risks, financial positioning, and a structured bull\/bear case share price target for 2026 and beyond.<\/p><p>Get free SEBI-registered analyst research on <strong>Aurobindo Pharma<\/strong> on <a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Univest<\/strong><\/a>.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Aurobindo_Pharma_Share_Price_%E2%80%94_Snapshot\" title=\"Aurobindo Pharma Share Price \u2014 Snapshot\">Aurobindo Pharma Share Price \u2014 Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#About_Aurobindo_Pharma\" title=\"About Aurobindo Pharma\">About Aurobindo Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Key_Growth_Catalysts_%E2%80%94_Aurobindo_Pharma_Share_Price_Target\" title=\"Key Growth Catalysts \u2014 Aurobindo Pharma Share Price Target\">Key Growth Catalysts \u2014 Aurobindo Pharma Share Price Target<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#1_Injectable_Business_Ramp\" title=\"1. Injectable Business Ramp\">1. Injectable Business Ramp<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#2_Europe_Generic_Business_Expansion\" title=\"2. Europe Generic Business Expansion\">2. Europe Generic Business Expansion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#3_Biosimilar_Pipeline\" title=\"3. Biosimilar Pipeline\">3. Biosimilar Pipeline<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Key_Risks_to_Watch\" title=\"Key Risks to Watch\">Key Risks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Risk_1_Promoter_governance_questions\" title=\"Risk 1: Promoter governance questions\">Risk 1: Promoter governance questions<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Risk_2_US_FDA_reinspection_at_Unit-4_injectable_facility_pending\" title=\"Risk 2: US FDA reinspection at Unit-4 injectable facility pending\">Risk 2: US FDA reinspection at Unit-4 injectable facility pending<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Aurobindo_Pharma_Share_Price_Target_2026\" title=\"Aurobindo Pharma Share Price Target 2026\">Aurobindo Pharma Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Short-Term_Target_3%E2%80%936_Months\" title=\"Short-Term Target (3\u20136 Months)\">Short-Term Target (3\u20136 Months)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#12-Month_Analyst_Consensus_Target\" title=\"12-Month Analyst Consensus Target\">12-Month Analyst Consensus Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Long-Term_Target_FY27%E2%80%93FY28\" title=\"Long-Term Target (FY27\u2013FY28)\">Long-Term Target (FY27\u2013FY28)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Q_What_is_Aurobindo_Pharma_share_price_target_for_2026\" title=\"Q: What is Aurobindo Pharma share price target for 2026?\">Q: What is Aurobindo Pharma share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Q_What_is_Aurobindo_Pharmas_current_share_price\" title=\"Q: What is Aurobindo Pharma&#8217;s current share price?\">Q: What is Aurobindo Pharma&#8217;s current share price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Q_Is_Aurobindo_Pharma_a_good_buy_at_current_levels\" title=\"Q: Is Aurobindo Pharma a good buy at current levels?\">Q: Is Aurobindo Pharma a good buy at current levels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Q_What_are_the_key_risks_for_Aurobindo_Pharma\" title=\"Q: What are the key risks for Aurobindo Pharma?\">Q: What are the key risks for Aurobindo Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Q_What_is_Aurobindo_Pharmas_market_cap_and_PE\" title=\"Q: What is Aurobindo Pharma&#8217;s market cap and P\/E?\">Q: What is Aurobindo Pharma&#8217;s market cap and P\/E?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Q_What_are_Aurobindo_Pharmas_growth_catalysts\" title=\"Q: What are Aurobindo Pharma&#8217;s growth catalysts?\">Q: What are Aurobindo Pharma&#8217;s growth catalysts?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Q_What_is_Aurobindo_Pharmas_long-term_target\" title=\"Q: What is Aurobindo Pharma&#8217;s long-term target?\">Q: What is Aurobindo Pharma&#8217;s long-term target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Q_Where_can_I_track_Aurobindo_Pharma_live\" title=\"Q: Where can I track Aurobindo Pharma live?\">Q: Where can I track Aurobindo Pharma live?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-share-price-target-2026\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aurobindo_Pharma_Share_Price_%E2%80%94_Snapshot\"><\/span><strong>Aurobindo Pharma Share Price \u2014 Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Parameter<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td>CMP (April 2026)<\/td><td>Rs 1,150<\/td><\/tr><tr><td>52-Week High<\/td><td>Rs 1,600<\/td><\/tr><tr><td>52-Week Low<\/td><td>Rs 1,050<\/td><\/tr><tr><td>Market Cap<\/td><td>Rs 67,000 Cr<\/td><\/tr><tr><td>Trailing P\/E<\/td><td>16x<\/td><\/tr><tr><td>NSE Ticker<\/td><td>AUROPHARMA<\/td><\/tr><tr><td>Sector<\/td><td>Pharma \/ US API \/ Injectable<\/td><\/tr><tr><td>12M Analyst Target<\/td><td>Rs 1,350\u20131,550<\/td><\/tr><tr><td>Bull Case<\/td><td>Rs 1,900<\/td><\/tr><tr><td>Bear Case<\/td><td>Rs 800<\/td><\/tr><tr><td>Upside (12M)<\/td><td>17\u201335%<\/td><\/tr><\/tbody><\/table><\/figure><p>Track <strong>Aurobindo Pharma<\/strong> live on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a> \u2014 fundamentals, FII\/DII flows, analyst ratings.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Aurobindo_Pharma\"><\/span><strong>About Aurobindo Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here \u2014 Get Free Investment Predictions on Univest<\/strong><\/a>.<\/p><p>Aurobindo Pharma is India&#8217;s second-largest pharma exporter with 600+ FDA-approved products. Its API backward integration provides cost advantage in all major therapeutic categories. Injectable capacity of 200 million vials is coming on stream in FY27.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Growth_Catalysts_%E2%80%94_Aurobindo_Pharma_Share_Price_Target\"><\/span><strong>Key Growth Catalysts \u2014 Aurobindo Pharma Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Tap to Access Best Research Pieces on Univest<\/strong><\/a>.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"1_Injectable_Business_Ramp\"><\/span><strong>1. Injectable Business Ramp<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Injectable Business Ramp \u2014 200 Million Vials Capacity Coming Online<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"2_Europe_Generic_Business_Expansion\"><\/span><strong>2. Europe Generic Business Expansion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Europe Generic Business Expansion \u2014 Germany and Spain Market Share<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"3_Biosimilar_Pipeline\"><\/span><strong>3. Biosimilar Pipeline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Biosimilar Pipeline \u2014 Adalimumab, Bevacizumab US Launches<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Risks_to_Watch\"><\/span><strong>Key Risks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_1_Promoter_governance_questions\"><\/span><strong>Risk 1: Promoter governance questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Promoter governance questions \u2014 historical precedent creates institutional discount<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_2_US_FDA_reinspection_at_Unit-4_injectable_facility_pending\"><\/span><strong>Risk 2: US FDA reinspection at Unit-4 injectable facility pending<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>US FDA reinspection at Unit-4 injectable facility pending<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aurobindo_Pharma_Share_Price_Target_2026\"><\/span><strong>Aurobindo Pharma Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro<\/strong><\/a> for premium analyst research on Aurobindo Pharma.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Short-Term_Target_3%E2%80%936_Months\"><\/span><strong>Short-Term Target (3\u20136 Months)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>In the near term, Aurobindo Pharma is expected to trade in the Rs 1,050\u2013Rs 1 range pending Q4 FY26 results and FY27 guidance clarity. The 52-week low of Rs 1,050 is the primary downside reference for position management.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"12-Month_Analyst_Consensus_Target\"><\/span><strong>12-Month Analyst Consensus Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The analyst consensus 12-month Aurobindo Pharma share price target is Rs 1,350\u20131,550 \u2014 implying 17\u201335% upside from Rs 1,150. This consensus assumes the primary catalysts materialise and macro conditions stabilise. These are analyst projections, not guaranteed returns. Check live targets on the Univest Screener.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Long-Term_Target_FY27%E2%80%93FY28\"><\/span><strong>Long-Term Target (FY27\u2013FY28)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The Aurobindo Pharma long-term target is Rs 1,900 in the bull case for FY27\u201328 \u2014 achievable if earnings delivery is consistent and catalysts accelerate. The bear case of Rs 800 represents the risk scenario if primary headwinds persist.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Scenario<\/strong><\/td><td><strong>Target Price<\/strong><\/td><td><strong>Key Assumption<\/strong><\/td><\/tr><tr><td>Bear<\/td><td>Rs 800<\/td><td>Headwinds persist; earnings miss; macro adverse<\/td><\/tr><tr><td>Base (12M)<\/td><td>Rs 1,350\u20131,550<\/td><td>Catalysts deliver; earnings in line; macro stabilises<\/td><\/tr><tr><td>Bull<\/td><td>Rs 1,900<\/td><td>Catalysts accelerate; beat; sector re-rates<\/td><\/tr><\/tbody><\/table><\/figure><p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> for live Aurobindo Pharma price and SEBI-registered analyst alerts.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Aurobindo Pharma at Rs 1,150 offers risk-reward of 17\u201335% to the 12-month analyst consensus of Rs 1,350\u20131,550. The bull case of Rs 1,900 is achievable on full catalyst delivery; the bear case Rs 800 is the downside reference. Track Q4 FY26 results and FY27 management guidance as the primary near-term catalysts for validating the Aurobindo Pharma share price target thesis.<\/p><p>For more stock research, visit <a href=\"https:\/\/univest.in\/blogs\">Univest Blogs<\/a>.<\/p><p><strong>Disclaimer: <\/strong>This article is for informational and educational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available data as of April 2026. Investments in securities are subject to market risk. Please consult a SEBI-registered financial advisor before making any investment decisions.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Aurobindo_Pharma_share_price_target_for_2026\"><\/span><strong>Q: What is Aurobindo Pharma share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The 12-month analyst consensus Aurobindo Pharma share price target is Rs 1,350\u20131,550, implying 17\u201335% upside from Rs 1,150. Bull case is Rs 1,900; bear case is Rs 800. These are analyst projections, not guaranteed returns.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Aurobindo_Pharmas_current_share_price\"><\/span><strong>Q: What is Aurobindo Pharma&#8217;s current share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Aurobindo Pharma (NSE: AUROPHARMA) trades at Rs 1,150 as of April 2026. 52-week high is Rs 1,600; 52-week low is Rs 1,050. Market cap is Rs 67,000 Cr.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_Is_Aurobindo_Pharma_a_good_buy_at_current_levels\"><\/span><strong>Q: Is Aurobindo Pharma a good buy at current levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>This article does not constitute investment advice. Aurobindo Pharma at Rs 1,150 has an analyst consensus target of Rs 1,350\u20131,550 implying 17\u201335% upside. Review catalysts and risks above and consult a SEBI-registered financial advisor before investing.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_are_the_key_risks_for_Aurobindo_Pharma\"><\/span><strong>Q: What are the key risks for Aurobindo Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Primary risks: Promoter governance questions \u2014 historical precedent creates institutional discount. Additionally: US FDA reinspection at Unit-4 injectable facility pending. Review the full risk analysis section for details.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Aurobindo_Pharmas_market_cap_and_PE\"><\/span><strong>Q: What is Aurobindo Pharma&#8217;s market cap and P\/E?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Aurobindo Pharma has market cap of Rs 67,000 Cr and trailing P\/E of 16x at Rs 1,150. 52-week range is Rs 1,050 to Rs 1,600.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_are_Aurobindo_Pharmas_growth_catalysts\"><\/span><strong>Q: What are Aurobindo Pharma&#8217;s growth catalysts?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Three key catalysts: Injectable Business Ramp, Europe Generic Business Expansion, and Biosimilar Pipeline.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Aurobindo_Pharmas_long-term_target\"><\/span><strong>Q: What is Aurobindo Pharma&#8217;s long-term target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The Aurobindo Pharma long-term share price target for FY27\u201328 is Rs 1,900 in the bull case \u2014 assuming consistent earnings delivery and full catalyst materialisation.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_Where_can_I_track_Aurobindo_Pharma_live\"><\/span><strong>Q: Where can I track Aurobindo Pharma live?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Track Aurobindo Pharma (NSE: AUROPHARMA) live on the Univest Screener at univest.in\/screeners. Download the Univest App for real-time alerts and SEBI-registered research.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/why-raymonds-share-price-falling\">Why is Raymond\u2019s Share Price Falling?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-gacm-technologies-share-price-falling\">Why is the GACM Technologies Share Price Falling?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-regaal-resources-share-price-falling\">Why is Regaal Resources Share Price Falling?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-mangalore-refinery-petrochemicals-share-price-falling\">Why is Mangalore Refinery &amp; Petrochemicals (MRPL) Share Price Falling?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-all-time-plastics-share-price-falling\">Why is All Time Plastics Share Price Falling?<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Aurobindo Pharma (NSE: AUROPHARMA) trades at Rs 1,150 as of April 2026 \u2014 against a 52-week high of Rs 1,600 and a 52-week low of Rs 1,050. The analyst consensus 12-month Aurobindo Pharma share price target is Rs 1,350\u20131,550, implying 17\u201335% upside. This article covers the key catalysts, risks, financial positioning, and a structured bull\/bear<\/p>\n","protected":false},"author":26,"featured_media":71757,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-71737","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"_edit_lock":["1776242034:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["842"],"rank_math_seo_score":["77"],"rank_math_focus_keyword":["Aurobindo Pharma"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Aurobindo Pharma Share Price Target 2026: Analyst Forecast, Bull and Bear "],"rank_math_description":["Aurobindo Pharma (NSE: AUROPHARMA) share price target 2026 \u2014 analyst consensus Rs 1,350\u20131,550. CMP Rs 1,150, bull case Rs 1,900, bear case Rs 800. 17\u201335% upside. Full analysis\n"],"_thumbnail_id":["71757"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["8179"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/15140035\/Aurobindo-Pharma-Share-Price-Target-.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/71737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=71737"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/71737\/revisions"}],"predecessor-version":[{"id":71759,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/71737\/revisions\/71759"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/71757"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=71737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=71737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=71737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}